Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
序贯 ALK 抑制剂可在 ALK 阳性肺癌中筛选出对劳拉替尼具有耐药性的化合物 ALK 突变
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-17-1256
Satoshi Yoda, Jessica J Lin, Michael S Lawrence, Benjamin J Burke, Luc Friboulet, Adam Langenbucher, Leila Dardaei, Kylie Prutisto-Chang, Ibiayi Dagogo-Jack, Sergei Timofeevski, Harper Hubbeling, Justin F Gainor, Lorin A Ferris, Amanda K Riley, Krystina E Kattermann, Daria Timonina, Rebecca S Heist,